Can we predict tumor outcome through cell-based proteomic assays?

By Jita De
Backed by Bruce H. Davis MD, Steven Grimm, and Eric Jorgenson
BiologyMedicine
$200
Raised of $40,000 Goal
1%
Ended on 10/12/13
Campaign Ended
  • $200
    pledged
  • 1%
    funded
  • Finished
    on 10/12/13

Lab Notes

This lab note is
for backers only

Morphoproteomic analysis of FACS-sorted CD133+ normal...
September 5, 2013
  • 0
  • 0
  • 8

This lab note is
for backers only

FCM of CD133+ hematopoietic stem cells
September 5, 2013
  • 0
  • 0
  • 5